NPR Examines Efforts To Get Chagas Disease Treatment Approved In U.S.

NPR: Drug For ‘Neglected’ Chagas Disease Gains FDA Approval Amid Price Worries
“…On Aug. 29 the FDA gave the global drug company Chemo Group approval to market its drug benznidazole in the U.S. … But it wasn’t easy. The story of how the decades-old treatment finally got approval for the U.S market is movie-worthy, with characters that include determined physicians and some of the nation’s poorest residents, as well as convicted securities fraudster and former drug company CEO Martin Shkreli…” (Columbus, 9/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.